Global Healthcare Cold Chain Logistics Market: Overview
The worldwide healthcare cold chain logistics market is analyzed to exhibit lucrative opportunities. With the rise of the demand for personalized medicine, healthcare cold chain logistics is expected to emerge as a preeminent and crucial facet in the process of the development and success of personalized drugs. Vendors such as QuickSTAT have already announced the significance of ‘complete chain of custody’ capabilities which can cater to the demanding requirements of personalized products, such as GPS-based alerts for possible postponements and incremented temperature monitoring. Besides this, companies such as Bolloré Logistics are looking to expand their logistics portfolio by earning important credentials such as the International Air Transport Association’s (IATA) Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) certification.
According to the authors of the report offered here, the global healthcare cold chain logistics market could be segmented on the basis of product type and technique. The geographical segmentation presented in the report provides an in-depth analysis of the current and future outlook of the global market while considering the major regions evaluated.
The analysts have unveiled some of the important factors responsible for the growth and cutback of the world healthcare cold chain logistics market. Buyers of the publication can also have access to a critical study about the current market trends, market structure, and market projection for the forthcoming years.
Global Healthcare Cold Chain Logistics Market: Trends
WHO had recently publicized the valuation of the global pharmaceutical market to rise from US$300.0 bn to US$400.0 bn within a period of only three years. This should give a strong impetus to the world healthcare cold chain logistics market since cold chain logistics is mostly involved in the safe and well-timed transportation of pharma products. The international market is anticipated to grow healthily with the introduction and adoption of new supply chain strategies and technologies in the industry. Most of the demand and growth in the global market is foreseen to arise from emerging economies such as India, which rakes in approximately 60.0% of its pharmaceutical revenue through exports. Interestingly, this revenue has inflated by a considerable percentage in the last few years.
Other factors deemed significant for the growth of the global healthcare cold chain logistics market include altering climatic conditions, inflating demand for economical and quality drugs in underdeveloped and developing countries, and easy online documentation required for the import and export of drugs. The demand is also foretold to increase with the rise of biopharmaceuticals on the back of players such as Serum Institute and Biocon in India.
Global Healthcare Cold Chain Logistics Market: Geography
The demand for healthcare cold chain logistics is envisaged to propel with the need for temperature-sensitive pharmaceuticals in developing regions and their appropriate transportation with the employment of temperature tags. Vendors are increasingly motivated to penetrate the emerging healthcare cold chain logistics markets due to high investments in cost-efficient technologies. Moreover, there is a worldwide need to maintain specific temperature requirements of insulin, frozen pharmaceutical, blood plasma, vaccine, and other healthcare products. This is also envisioned to push the global market in different geographies such as North America, Europe, Asia Pacific, and Rest of the World.
Global Healthcare Cold Chain Logistics Market: Competition
Some of the leading firms that are making a mark in the international healthcare cold chain logistics market are DHL International GmbH, United Parcel Service, Inc., Continental Air Cargo, LifeConEx LLC, Kuehne and Nagel International AG, World Courier, DB Schenker, Inc., and FedEx Corporation.
Apart from a broad overview of the competitive scenario of the global market, the report has shed light on the salient micro and macro factors that are important for the new entrants as well as established players in the industry.
Market segmentation based on product:
- Clinical Trial Materials
Market segmentation based on technique:
- Dry Ice
- Liquid Nitrogen
- Gel Packs
Market segmentation based on geography:
- North America
- Asia Pacific
- Rest of the World
Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.